In silico clinical trials for relapsing-remitting multiple sclerosis with MS TreatSim

BACKGROUND: The last few decades have seen the approval of many new treatment options for Relapsing-Remitting Multiple Sclerosis (RRMS), as well as advances in diagnostic methodology and criteria. These developments have greatly improved the available treatment options for today’s Relapsing-Remittin...

Descripción completa

Detalles Bibliográficos
Autores principales: Sips, Fianne L. P., Pappalardo, Francesco, Russo, Giulia, Bursi, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665027/
https://www.ncbi.nlm.nih.gov/pubmed/36380294
http://dx.doi.org/10.1186/s12911-022-02034-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665027/
https://www.ncbi.nlm.nih.gov/pubmed/36380294
http://dx.doi.org/10.1186/s12911-022-02034-x

Ejemplares similares